Latest Reports April 28, 2008. Sprott's Timminco dealings openly questioned April 23, 2008. Timminco¹s convoluted dealings and "furious" insider selling comes to light. April 22, 2008. Q-Cells acknowledges having no relevant information on Timminco. April 21, 2008. Globe and Mail changes course on Timmico stock promotion. March 31, 2008. Q-Cells makes outlandishly conflicting claims about upgraded metallurgical silicon. Home Site Map Site Map Home Overview About Us What we do Biography Investment Record Track Record Investor Advocacy Research Methodology About Us What we do About Manuel Asensio Investment Record Track Record Research Methodology Investor Advocacy Biography Biography Investor Advocacy Research Methodology Track Record Investment Record About Asensio & Company History Press Quotes Research Legacy The Winstar Story The Solv-Ex Story The Hemispherx Story 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 History War Stories The Hemispherx Story The Solv-Ex Story The Winstar Story Press List 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Press Quotes Research Legacy Reports Archive Letter to companies Letters Pre October 30, 2003 Able Telcom Holding Corp. Manuel Asensio Report: Dec. 2,1999 Able Telcom discloses SEC investigation of its accounting fraud. Manuel Asensio Report: Mar. 17, 1999 Able reduces preferred price to $3.50, reports false earnings. Manuel Asensio Report: March 01, 1999 - Able faces possible delisting. Manuel Asensio Report: Feb. 26, 1999 Able pays Kaufman Bros., L.P. Manuel Asensio Report: Feb. 24, 1999 Able discloses rapid financial deterioration and insolvency. Manuel Asensio Report: Feb. 04, 1999 NJ legislator requests E-Z Pass investigation Manuel Asensio Report: Feb. 02, 1999 Able admits receiving redemption notice. Manuel Asensio Report: Feb. 01, 1999 Able Telcom fails to file 10-K. Manuel Asensio Report: Jan. 27, 1999 Able's Young and his Interfiducia. Manuel Asensio Report: Jan. 25, 1999 Analysis of NJTA's letter agreement with Able's MFS NT. Manuel Asensio Report: Jan. 25, 1999 Able's scheduled restructuring. Manuel Asensio Report: Jan. 20, 1999 Able's failure exposes New Jersey official. Manuel Asensio Report: Jan. 14, 1999 Able Telcom restates NYSTA deal. Manuel Asensio Report: Jan. 12, 1999 Able's Deal Short and Misrepresented. Manuel Asensio Report: Jan. 11, 1999 Able Telcom's stock rises after analyst issues false report. Manuel Asensio Report: Jan. 08, 1999 Able Telcom defaults on stock registration obligation. Manuel Asensio Report: Jan. 08, 1999 ABTE declared in default of New Jersey project contract. Manuel Asensio Report: Sept. 15, 1998 Able fails to file Form 10Q and its auditors resign. Manuel Asensio Report: Sept. 01, 1998 Able Telcom fails to pay secured debt obligation. Manuel Asensio Report: Aug. 21, 1998 Able Telcom director charged with fraud. Manuel Asensio Report: Aug. 20, 1998 Able‚Äôs new hires fail to replace lost MFS officers. Manuel Asensio Report: Aug. 14, 1998 Able Telcom obligated to prepay Senior Subordinated Notes. Manuel Asensio Report: Jul. 17, 1998 Able attempts to blame stock drop on preferred. Manuel Asensio Report: Jul. 16, 1998 Able's dire financial condition begins to unfold. Avant! Corporation Manuel Asensio Report: Jul. 20, 1998 Avant!'s day of reckoning draws closer. Manuel Asensio Report: Feb. 27, 1998 Avant!'s Apollo begins to draw fire. Manuel Asensio Report: Jan. 08, 1998 Cadence reports large increase in place and route transition. Manuel Asensio Report: Jan. 07, 1998 Avant! Announced No Incremental Revenue Increase Manuel Asensio Report: Dec. 29, 1997 Avant! analyst fails to disclose conflict of interest. Manuel Asensio Report: Dec. 23, 1997 Wessels, Arnold publishes erroneous report. Manuel Asensio Report: Dec. 22, 1997 Aquarius injunction is imminent. Manuel Asensio Report: Dec. 16, 1997 Avant! suffers series of negative litigation developments. Manuel Asensio Report: Nov. 04, 1997 Avant!'s DRC market share grossly overstated. Manuel Asensio Report: Oct. 15, 1997 Avant! reports dismal third quarter results. Manuel Asensio Report: Oct. 15, 1997 Avant!'s Compass dealings exposed. Manuel Asensio Report: Aug. 21, 1997 Avant! reported to be losing market share. Manuel Asensio Report: Aug. 01, 1997 Strong Sell Recommendation Avid Technology, Inc. Manuel Asensio Report: Sept. 04, 2003 Why are AVID insiders screaming that the stock is overvalued? BioTime Manuel Asensio Report: Nov. 05, 1998 BioTime officers retract statements regarding FDA approval. Manuel Asensio Report: Nov. 05, 1998 BioTime loses its prime sponsor. Manuel Asensio Report: Oct. 26, 1998 BioTime posters fail to generate interest or support claims. Manuel Asensio Report: Oct. 26, 1998 BioTime Hextend fails to meet priority review standards. Manuel Asensio Report: May 17, 1998 BioTime analyst issues false report. Manuel Asensio Report: Apr. 29, 1998 BioTime possesses no valuable product or technology. Manuel Asensio Report: Apr. 29, 1998 STRONG SELL RECOMMENDATION Manuel Asensio Report: Jan. 22, 1998 - BioTime Strong Sell Recommendation Published in Forbes. Manuel Asensio Report: Dec. 06, 1996 Cellular Technical Services possesses no valuable technology. Biovail Corporation International Manuel Asensio Report: Sept. 09, 1997 BVF's Cardizem CD will not reverse sales/earnings decline. Manuel Asensio Report: Sept. 13, 1996 Strong Sell Recommendation. Black Box Corporation Manuel Asensio Report: Mar. 13, 2003 BBOX Wednesday from an investor advocate's point of view. Cellular Technical Services Company, Inc. Manuel Asensio Report: Dec. 06, 1996 Cellular Technical Services possesses no valuable technology. Manuel Asensio Report: Dec. 05, 1996 Asensio & Co., Inc. issues a Sell Rec. on Cellular Tech. Chromatics Color Sciences International, Inc. Manuel Asensio Report: Apr. 02, 2002 Courts uphold Asensio research and short sales trading. Manuel Asensio Report: Apr. 02, 2002 Asensio & Company, Inc. wins second jury verdict. Manuel Asensio Report: Jun. 26, 1998 Former Bre-X consultant promotes Chromatics‚Äô stock. Manuel Asensio Report: Jun. 23, 1998 AMA denies permitting insurance reimbursement for CCSI. Manuel Asensio Report: Jun. 23, 1998 CCSI's disposable shown to be senseless. Manuel Asensio Report: Jun. 12, 1998 Chromatics' stock fraud exposed. Manuel Asensio Report: Jun. 12, 1998 Dreyfus fund manager engaged in fraudulent activities. Manuel Asensio Report: Jun. 09, 1998 STRONG SELL RECOMMENDATION Coinmach Laundry Corporation Manuel Asensio Report: Sept. 29, 1998 Coinmach continues to lose cash and not grow. Manuel Asensio Report: May 21, 1998 Coinmach releases lower than announced Macke results. Manuel Asensio Report: May 13, 1998 Coinmach reports 7.7% decline in EBITDA Manuel Asensio Report: May 13, 1998 Coinmach fails to disclose BT Alex Brown interest conflict. Manuel Asensio Report: May 11, 1998 Coinmach suffers dramatic reduction in shareholder base. Manuel Asensio Report: Mar. 12, 1998 Coinmach omits $17.8 million deduction from cash flow formula Manuel Asensio Report: Feb. 12, 1998 Coinmach Laundry misrepresents S&P ratings implication. Manuel Asensio Report: Feb. 12, 1998 Coinmach possesses no free cash flow. Cross Media Marketing Corporation Manuel Asensio Report: Jul. 17, 2002 Cross Media expects second quarter loss, cuts operations. Crystallex International Corporation Manuel Asensio Report: Mar. 26, 1998 Crystallex pays for ads containing false information. Manuel Asensio Report: Mar. 23, 1998 Venezuelan Government in agreement with Acosta's statements. Manuel Asensio Report: Mar. 22, 1998 Crystallex promoter publishes false report. Manuel Asensio Report: Mar. 22, 1998 Crystallex's Fung and Nihon issue implausible denials. Manuel Asensio Report: Mar. 18, 1998 Crystallex fails to deny new fraud charges. Manuel Asensio Report: Mar. 18, 1998 KRY insiders continue to benefit from its stock promotion. Manuel Asensio Report: Mar. 05, 1998 No Uncertainty AboutTitle to Las Cristinas gold concessions. Manuel Asensio Report: Mar. 05, 1998 Crystallex transfers $13.7 million to directors' company. Manuel Asensio Report: Mar. 05, 1998 Crystallex issued yet another false statement. Manuel Asensio Report: Mar. 04, 1998 Crystallex has no claim to Las Cristinas gold Manuel Asensio Report: Mar. 04, 1998 Crystallex reports false info on its Las Cristinas claims. Manuel Asensio Report: Mar. 04, 1998 Trading in Oppenheimer's prior stock promotion halted. Diana Corporation Manuel Asensio Report: Aug. 07, 1997 Diana filing reveals negative impact of recent financings. Manuel Asensio Report: Jul. 17, 1997 Diana will realize no gain from Concentric's offering or suit. Manuel Asensio Report: Nov. 14, 1996 Diana issues yet another false statement. Manuel Asensio Report: Oct. 24, 1996 Investigation finds Diana's rebuttals to be completely untrue. Manuel Asensio Report: Oct. 16, 1996 Asensio & Company serves demand on Diana. Manuel Asensio Report: Oct. 15, 1996 Asensio & Company releases summary of Diana engineering study. Manuel Asensio Report: Oct. 15, 1996 Engineering study finds important discrepancies Sattel's claims Manuel Asensio Report: Oct. 15, 1996 STRONG SELL RECOMMENDATION Manuel Asensio Report: Sept. 06, 1996 Fund Manager Buys Diana Stock Privately at $20 Per Share Manuel Asensio Report: Jul. 26, 1996 Diana Loudly Rings The Closing Bell. Manuel Asensio Report: Jul. 23, 1996 Asensio & Co. reconfirms its Strong Sell rec. of Diana Manuel Asensio Report: Jul. 02, 1996 Diana's new 10K provides proof of fraud. Manuel Asensio Report: Jun. 27, 1996 Asensio & Co. reconfirmed its Strong Sell rec. on Diana Manuel Asensio Report: Jun 25, 1996 DNA shares remain grossly overvalued Manuel Asensio Report: Jun. 06, 1996 Diana fails to deny its stock is "grossly over-inflated" Manuel Asensio Report: Jun. 04, 1996 Strong Sell Rec. - The Diana Corporation Ergobilt Manuel Asensio Report: Oct. 06, 1997 ErgoBilt fails to dispute disclosure failures. Manuel Asensio Report: Sept. 30, 1997 ErgoBilt fails to disclose adverse court decision. Manuel Asensio Report: Sept. 24, 1997 ErgoBilt fraudulently promotes obsolete technology. Manuel Asensio Report: Sept. 24, 1997 Asensio & Company issues Strong Sell on ErgoBilt, Inc. General Nutrition Companies, Inc. Manuel Asensio Report: Jan. 19, 1996 The Closing Bell Falls on Deaf Ears Manuel Asensio Report: Jan. 18, 1996 Strong Sell Recommendation Hemispherx Biopharma, Inc. Manuel Asensio Report: May 30, 2003 Bloomberg: Short-Sellers Asensio and Chanos Are Men to Beat Manuel Asensio Report: Jul. 14, 2002 "Ill Will" published in the Philadelphia Inquirer. Manuel Asensio Report: Feb. 22, 2002 Jury finds Asensio did not defame Hemispherx. Manuel Asensio Report: Feb. 22, 2002 HEB‚Äôs questionable defamation case under jury deliberation. Manuel Asensio Report: Feb. 02, 2002 Letter to Congress on significance of HEB's corporate misdeeds. Manuel Asensio Report: Jan. 28, 2002 NASD's AMEX censured, floor chief barred and Chairman resigns Manuel Asensio Report: Dec. 18, 2001 Even Carter‚Äôs co-conspirator objects to smallpox claims. Manuel Asensio Report: Dec. 18, 2001 HEB uses anti-terrorism scam in AMEX pump and dump operation Manuel Asensio Report: Oct. 02, 2001 AMEX‚Äôs Hemispherx stock fraud exceeds 30 million shares. Manuel Asensio Report: Sept. 25, 2001 Ampligen and its clinical trials found flawed and useless Manuel Asensio Report: Jul. 25, 2000 Hemispherx cited in three criminal indictments. Manuel Asensio Report: Jun. 08, 2000 Asensio wins against Hemispherx. Manuel Asensio Report: Jun. 01, 2000 KPMG terminates its audit relationship with Hemispherx. Manuel Asensio Report: Apr. 19, 2000 Hemispherx‚Äôs forced to make damning admissions. Manuel Asensio Report: Aug. 10, 1999 Hemispherx continues attempts to control its stock trading. Manuel Asensio Report: Aug. 10, 1999 Letter to FDA regarding Hemispherx cost recovery. Manuel Asensio Report: Jul. 29, 1999 Yet another fraudulent stock promoter tied to Hemispherx. Manuel Asensio Report: Jul. 14, 1999 Hemispherx fabricates false quotes from CFIDS Network. Manuel Asensio Report: Jul. 13, 1999 HEB's Carter tied to "advocacy group" promotion of Ampligen Manuel Asensio Report: May 21, 1999 Hemispherx officers tied to other manipulated stocks. Manuel Asensio Report: May 13, 1999 AMEX fails to commence enforcement action against Hemispherx. Manuel Asensio Report: May 13, 1999 Compilation of HEB‚Äôs fraudulent investor representations. Manuel Asensio Report: Mar. 18, 1999 Hemispherx Suffers Major Loss in Federal Court. Manuel Asensio Report: Nov. 18, 1998 Hemispherx report reveals insider "pump and dump" operation. Manuel Asensio Report: Oct. 28, 1998 Hemispherx confirms failure to disclose FDA violation. Manuel Asensio Report: Oct. 27, 1998 FDA determines HEB‚Äôs Ampligen claims violate regulations. Manuel Asensio Report: Oct. 14, 1998 Hemispherx‚Äôs hubris expands to legal profession. Manuel Asensio Report: Oct. 01, 1998 Carter‚Äôs DuPont/Stratton-Oakmont claims show intent to defrau Manuel Asensio Report: Sept. 30, 1998 Hemispherx attempts to prevent stock sale. Manuel Asensio Report: Sept. 22, 1998 Asensio & Co. releases research report on HEB. Manuel Asensio Report: Sept. 22, 1998 STRONG SELL RECOMMENDATION Hemispherx section: AIDS-based stock fraud Manuel Asensio Report: May 03, 2002 Hemispherx continues to renew its fraudulent AIDS promotion Manuel Asensio Report: Nov. 21, 2001 Even Carter‚Äôs co-conspirator objects to latest scam Manuel Asensio Report: Jul. 26, 2000 FDA charges HEB with false and misleading Ampligen promote. Manuel Asensio Report: Mar. 17, 2000 Hemispherx charged with deception by AIDS organization Manuel Asensio Report: May 11, 1999 HEB analyst makes false Ampligen HIV claims despite failed test Hemispherx section: CFS-based stock fraud Manuel Asensio Report: Dec. 18, 2001 Hemispherx grossly misrepresents AHRQ report. Manuel Asensio Report: Feb. 08, 2001 Hemispherx issues yet another false and fraudulent release. Manuel Asensio Report: Dec. 08, 1998 Leading researchers find CFS to be psychosomatic. Manuel Asensio Report: Oct. 28, 1998 Hemispherx‚Äôs CFS prevalence disclosures proven false. Manuel Asensio Report: Oct. 28, 1998 Hemispherx issues false and exaggerated CFS prevalence rates Manuel Asensio Report: Oct. 27, 1998 Hemispherx issues blatantly false FDA infraction statement. Manuel Asensio Report: Oct. 14, 1998 HEB CFS Phase III/orphan approvals found to be six years old. Manuel Asensio Report: Oct. 13, 1998 Ampligen Safety Profile. Manuel Asensio Report: Oct. 12, 1998 Hemispherx‚Äôs CFS conference presentations widely ignored. Manuel Asensio Report: Oct. 08, 1998 Hemispherx distributes fraudulent Oprah Winfrey videotape. Manuel Asensio Report: Oct. 01, 1998 Hemispherx exposed to FDA sanctions. Manuel Asensio Report: Sept. 30, 1998 Letter to FDA concerning HEB violation of FDA regulations Manuel Asensio Report: Sept. 30, 1998 Hemispherx attempts to use false CFS prevalence rate Manuel Asensio Report: Sept. 30, 1998 Hemispherx continues fraudulent stock promotion. Manuel Asensio Report: Sept. 24, 1998 HEB Announces Deal with Convicted Former-NCI Researcher. Manuel Asensio Report: Sept. 22, 1998 Hemispherx‚Äôs Ampligen has no medical or economic value. Intersil Holding Corp. Manuel Asensio Report: Dec. 07, 2000 Short Seller raised concerns prior pre-announcement. Manuel Asensio Report: Sept. 14, 2000 Intersil falls far behind in next generation Wireless LAN. Lyondell Chemical Company Manuel Asensio Report: Oct. 27, 1998 Lyondell grossly overvalued Multimedia Games, Inc. Manuel Asensio Report: Oct. 09, 2003 MGAM tells customers to discontinue Reel Time Bingo play. Manuel Asensio Report: Oct. 09, 2003 NIGC names Reel Time Bingo a non-conforming game. Manuel Asensio Report: Oct. 02, 2003 MGAM failed to obtain Class II classification for its games. Manuel Asensio Report: Oct. 02, 2003 MGAM NIGC brinkmanship creates new problems for its customers. Network Solutions Manuel Asensio Report: Sept. 29, 1999 NSOL‚Äôs .com monopoly terminated. Manuel Asensio Report: Jul. 09, 1999 U.S. Dept. of Commerce confirms pending NSOL contract Manuel Asensio Report: May 06, 1999 NSOL's insider sold stock shortly before ICANN designation. Manuel Asensio Report: Apr. 28, 1999 Letter to U.S. Sec. of Commerce Daley concerning NSOL Manuel Asensio Report: Apr. 22, 1999 NSOL fails to obtain DOC approval for registry fee. Manuel Asensio Report: Apr. 12, 1999 NSOL forced to reverse InterNIC take-over. Manuel Asensio Report: Apr. 08, 1999 NSOL analyst issues false report. Manuel Asensio Report: Apr. 08, 1999 NSOL faces $2 registry fee bid. Manuel Asensio Report: Mar. 25, 1999 Network Solutions fails to disclose government notification. Manuel Asensio Report: Mar. 25, 1999 NSOL possesses no lock on domain registry, etc. On2 Technologies, Inc. Manuel Asensio Report: Jul. 18, 2003 AMEX continues to list a questionable stock. ParkerVision, Inc. Manuel Asensio Report: Mar. 20, 2003 Little secrets spill out about a Barron's roundtable favorite. Manuel Asensio Report: Nov. 23, 1999 ParkerVision promoters charged with stock fraud. Manuel Asensio Report: Oct. 19, 1999 ParkerVision‚Äôs Ferraro resorts to "stupidity" excuse. Manuel Asensio Report: Oct. 15, 1999 ParkerVision‚Äôs Ferraro/Gottardo/Whale stock scam exposed. Manuel Asensio Report: Oct. 15, 1999 PRKR's financial mastermind suspended, according to Fortune. Manuel Asensio Report: Oct. 14, 1999 ParkerVision added to Symbol‚Äôs suspect deals. Manuel Asensio Report: Oct. 14, 1999 ParkerVision finally announces its new bogus deal. Manuel Asensio Report: Oct. 12, 1999 ParkerVision‚Äôs claims refuted by its own website disclosures. Manuel Asensio Report: Oct. 01, 1999 PRKR has no D2D patents. D2D site contains no new information. Manuel Asensio Report: Sept. 30, 1999 ParkerVision fails to deny stock is "grossly over-inflated" Manuel Asensio Report: Sept. 28, 1999 Boeing official refutes ParkerVision's product claims. Manuel Asensio Report: Sept. 28, 1999 ParkerVision possesses no valuable technology. PolyMedica Corporation Manuel Asensio Report: Sept. 26, 2003 The inner workings of the quadrupling of PLMD's stock price. Manuel Asensio Report: Sept. 09, 2003 PolyMedica's criminal prosecution firmly on track. Manuel Asensio Report: Jun. 30, 2003 PLMD's "advertising costs do not qualify for capitalization" Manuel Asensio Report: May 07, 2003 So Herbert Denton is a "shareholder activist"? Manuel Asensio Report: Feb. 18, 2003 USA TODAY: Short sellers sharply scrutinize companies. Manuel Asensio Report: Jan. 03, 2003 PLMD tells employees to keep information from investigators Manuel Asensio Report: Oct. 31, 2002 End of PolyMedica‚Äôs Medicare "bonanza" draws closer. Manuel Asensio Report: Oct. 31, 2002 Rules affecting PLMD‚Äôs pricing scheduled for November release Manuel Asensio Report: Sept. 17, 2002 Taxpayer funding used to support PolyMedica‚Äôs stock promotio Manuel Asensio Report: Aug. 13, 2002 Asensio & Co. issues two new reports on PLMD. Manuel Asensio Report: Aug. 13, 2002 PLMD‚Äôs "hidden" losses surpass $55 million. Manuel Asensio Report: Aug. 13, 2002 Why did Mr. Lee leave without notice? Manuel Asensio Report: Jun. 14, 2002 PLMD now faces revenue reductions on top of its investigation. Manuel Asensio Report: May 30, 2002 More Concerns for PolyMedica's Oversight Chairman Manuel Asensio Report: May 20, 2002 PLMD‚Äôs reported earnings raise serious legitimacy concerns. Manuel Asensio Report: May 15, 2002 PolyMedica's feeble attempts at credibility exposed. Manuel Asensio Report: Apr. 23, 2002 PolyMedica‚Äôs SEC claim is doubtful and immaterial. Manuel Asensio Report: Oct. 25, 2001 Wall Street‚Äôs cynical greed on display at Polymedica. Manuel Asensio Report: Oct. 25, 2001 Safeco involved in dealings with PLMD, reports Asensio & Co. Research Frontiers Incorporated Manuel Asensio Report: Jun. 06, 2002 Update on our Research Frontiers forecast Manuel Asensio Report: Dec. 20, 2001 Asensio's nine (9) page letter to REFR dated June 14, 2001. Manuel Asensio Report: Dec. 20, 2001 REFR fails to address questionable disclosures etc Manuel Asensio Report: Dec. 20, 2001 Asensio's three page letter to REFR dated November 15, 2001. Manuel Asensio Report: Dec. 11, 2001 Korean promotion shows REFR's tricks, says Asensio & Co. Manuel Asensio Report: Nov. 29, 2001 REFR blows $11.3 million reports Asensio & Co. Manuel Asensio Report: Nov. 28, 2001 REFR joins list of bad penny-stock deals, reports Asensio & Co. Manuel Asensio Report: Nov. 21, 2001 InspecTech TTF claims misleading, reports Asensio & Co. Manuel Asensio Report: Sept. 18, 2001 REFR‚Äôs promotion causes capital misallocation, reports Asens Manuel Asensio Report: Sept. 11, 2001 REFR‚Äôs false ‚Äònews‚Äô story exposed, reports Asensio & Co. Manuel Asensio Report: Sept. 06, 2001 REFR's bogus patent promotion exposed, reports Asensio & Co. Manuel Asensio Report: Aug. 24, 2001 REFR‚Äôs "short squeeze" is a myth, reports Asensio & Co. Manuel Asensio Report: Aug. 24, 2001 REFR remains grossly overvalued, reports Asensio & Co. Manuel Asensio Report: Aug. 22, 2001 REFR‚Äôs silly circus takes to the air, reports Asensio & Co. Manuel Asensio Report: Jul. 12, 2001 REFR involved in yet another questionable deal. Manuel Asensio Report: Jun. 18, 2001 REFR uses old promotion in its new story, reports Asensio & Co. Manuel Asensio Report: Jun. 15, 2001 REFR issues unsubstantiated future profit forecast. Rica Foods, Inc. Manuel Asensio Report: Mar 10, 2003 Another AMEX Scam Bites the Dust. Solv-Ex Corporation Manuel Asensio Report: May 09, 2000 Solv-Ex Suit Against Asensio & Company Dismissed. Manuel Asensio Report: Oct. 09, 1997 Solv-Ex has no valuable asset to sell and no bids of any kind. Manuel Asensio Report: Oct. 03, 1997 Solv-Ex shareholder value eliminated. Manuel Asensio Report: Jul. 03, 1997 Solv-Ex possesses no titanium dioxide product. Manuel Asensio Report: Jun. 26, 1997 Solv-Ex technical employee provides definitive proof of fraud. Manuel Asensio Report: Jun. 24, 1997 Solv-Ex attempts new Reg S offering Manuel Asensio Report: Jun. 11, 1997 Solv-Ex possesses no valuable reserves. Manuel Asensio Report: May 27, 1997 Asensio provides testimony against Solv-Ex. Manuel Asensio Report: May 20, 1997 Solv-Ex's latest Form 10Q reveals its true state of affairs. Manuel Asensio Report: May 20, 1997 Solv-Ex's 10Q filing confirms its production claims are false. Manuel Asensio Report: May 13, 1997 SEC conducts discovery in its investigation of Solv-Ex. Manuel Asensio Report: May 12, 1997 Asensio & Company agrees to give testimony against Solv-Ex Manuel Asensio Report: May 02, 1997 Solv-Ex's AEUB approval claims are completely false. Manuel Asensio Report: May 02, 1997 New Solv-Ex lawsuit clearly proves misrepresentations Manuel Asensio Report: Apr. 07, 1997 Solv-Ex's "production" claims shown to be false. Manuel Asensio Report: Apr. 02, 1997 Solv-Ex fails to get regulatory approval. Manuel Asensio Report: Mar. 27, 1997 Solv-Ex puts false spin on temporarily rigged plant. Manuel Asensio Report: Mar. 13, 1997 Solv-Ex defaults on $33 million loan. Manuel Asensio Report: Mar. 11, 1997 Request for NASDAQ Listing Review Manuel Asensio Report: Mar. 10, 1997 Solv-Ex forced to cancel conference call. Manuel Asensio Report: Mar. 07, 1997 Solv-Ex's schedule claims are completely false and untrue. Manuel Asensio Report: Mar. 07, 1997 Asensio & Company's correspondence with Deutsche Bank. Manuel Asensio Report: Mar. 03, 1997 Solv-Ex's own documents show itsclaims to be false. Manuel Asensio Report: Feb. 26, 1997 Solv-Ex fires the entire plant start-up crew. Manuel Asensio Report: Feb. 25, 1997 Nothing in Solv-Ex's entire plant works. Manuel Asensio Report: Feb. 20, 1997 SEC is Trailing Proceeds From Solv-Ex Transactions Manuel Asensio Report: Feb. 19, 1997 Mgnt's representations concerning Solv-Ex's progress are false Manuel Asensio Report: Feb. 03, 1997 Solv-Ex acknowledges Federal Grand Jury investigation. Manuel Asensio Report: Oct. 07, 1996 Solv-Ex's dealings with MorganGrenfell begin to unfold. Sterling Vision Manuel Asensio Report: Aug. 19, 1997 ISEE false reports allow insiders to sell at inflated prices. SyQuest Technology Inc. Manuel Asensio Report: May 24, 1996 Strong Sell Recommendation Turbodyne Technologies, Inc. Manuel Asensio Report: Mar. 20, 2000 Asensio and Turbodyne resolve their dispute. Manuel Asensio Report: Dec. 20, 1999 Turbodyne‚Äôs auditors resign. Manuel Asensio Report: Jan. 21, 1999 Turbodyne stock halted by Market Authorities. Manuel Asensio Report: Dec. 16, 1998 Turbodyne makes futile attempt to gain credibility. Manuel Asensio Report: Aug. 26, 1998 Turbodyne continues to promote non-existing UN endorsement. Manuel Asensio Report: Aug. 20, 1998 Turbodyne's UN endorsements are blatantly false. Manuel Asensio Report: Aug. 05, 1998 Turbodyne fails to deny stock fraud charge. Manuel Asensio Report: Aug. 04, 1998 Turbodyne possesses no valuable technology. VeriSign, Inc. Manuel Asensio Report: Aug. 30, 2001 Asensio reiterates its VRSN Strong Sell and Short Sell Rec. Manuel Asensio Report: May 21, 2001 No DOC ruling on ICANN's jurisdiction. Manuel Asensio Report: May 16, 2001 ICANN‚Äôs Chairman had undisclosed conflict of interest Manuel Asensio Report: May 08, 2001 Another dubious attempt to predict public policy. Manuel Asensio Report: May 07, 2001 Six More Years of Monopoly.com? Manuel Asensio Report: May 07, 2001 ICANN fails to obtain necessary approval for VeriSign deal Manuel Asensio Report: May 03, 2001 VRSN and its analysts have sown investor disappointment. Manuel Asensio Report: May 03, 2001 Peering into VeriSign's Foolish $12 Billion Bubble. Manuel Asensio Report: May 02, 2001 VeriSign‚Äôs divestiture deadline being unduly disregarded. Winstar Communications, Inc. Manuel Asensio Report: Mar. 30, 2001 No evident reason to repurchase Winstar shares. Manuel Asensio Report: Mar. 19, 2001 WCII‚Äôs debt collapse reflects its cash and operating crisis. Manuel Asensio Report: Mar. 14, 2001 Salomon Smith Barney Issues Misleading Winstar Report.